Asset Management One’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Asset Management One's MRNA Position: Q3 2026 in Review
Asset Management One increased its Moderna (MRNA) stake by 3.4% in Q3 2026, buying an estimated $76.6K and bringing the position to 21,713 shares worth $4.18M. The position accounts for 0.01% of the portfolio, ranked #621.
Asset Management One first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. The position peaked at $59.4M in Q3 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Asset Management One held 21,713 shares of Moderna worth $4.18M as of Q3 2026.
- Asset Management One bought 711 Moderna shares in Q3 2026, an estimated $76.6K.
- Moderna made up 0.01% of Asset Management One's portfolio in Q3 2026, its #621 holding.
- Asset Management One first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
- Asset Management One's Moderna position peaked at $59.4M in Q3 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Asset Management One's 13F filing for Q3 2026, filed 27 Oct 2026.